Molecular analysis supports therapy decisions in rare cancers -- MEDICA - World Forum for Medicine

Molecular analysis supports therapy decisions in rare cancers

25.06.2021

Image: A hand with a pen points at a screen with medical data; Copyright: NCT Heidelberg/Philip Benjamin

The DKFZ/NCT/DKTK-MASTER program serves the multidimensional characterization of patients with advanced rare cancers and patients diagnosed with incurable cancer at an unusually early age.

Products and exhibitors around biomarkers

Image: Small brown glass bottles with colorful caps; Copyright: Messe Düsseldorf

More topic-related exciting news from the editors of MEDICA-tradefair.com